Shanghai Haohai Biological Technology Co., Ltd. (688366.SS) SHH

Currency In CNY

AD

Valuation

Market Cap10.2B
Enterprise Value8.15B
P/E Ratio30.93
PEG Ratio-0.45
Price/Sales Ratio2.47
Price/Book Ratio1.31
Enterprise/Revenue1.68
Enterprise/EBITDA12.05

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.1
Operating Margin0.08
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.04

Income Statement

Revenue2.47B
Revenue/Share10.76
Gross Profit1.6B
EBITDA416.56M
Net Income251.01M
Diluted EPS1.08

Balance Sheet

Total Cash2.41B
Total Cash/Share10.69
Total Debt417.41M
Total Debt/Equity0.08
Current Ratio3.73
Book Value Per Share24.83

Price History

52-Week Change-36.38
52-Week High58.97
52-Week Low29.2
Moving Average 50 Days36.05
Moving Average 200 Days44.26

Statistics

Average Volume552,052
Shares Outstanding190.2M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1
Trailing Annual Dividend Yield3.17
Payout Ratio1.33
Last Split Factor7:5
Last Split DateJune 20, 2024
AD